20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9806 | NVP-DKY709 | Others | |
NVP-DKY709 is a potent IKZF2 inhibitor for the treatment of cancers. | |||
T2680 | NVP-BVU972 | c-Met/HGFR | |
NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM. | |||
T6348 | NVP-BHG712 | Raf , Bcr-Abl , Src , Ephrin Receptor | |
NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respecti... | |||
T6294 | NVP-BSK805 2HCl (1092499-93-8(free base)) | NVP-BSK805 dihydrochloride,BSK 805,NVP-BSK805 (dihydrochloride) | Tyrosine Kinases , JAK |
NVP-BSK805 2HCl (1092499-93-8(free base)) (BSK 805)(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2. | |||
T1933 | NVP 231 | Apoptosis , ERK | |
NVP-231 is a potent, specific and reversible CerK inhibitor(IC50=12±2 nM) that competitively inhibits ceramide binding to CerK. | |||
T16363 | NVP-2 | Apoptosis , CDK | |
NVP-2 is an effective and selective ATP-competitive cyclin-dependent kinase 9 (CDK9) probe. NVP-2 induces cell apoptosis. NVP-2 inhibits CDK9/CycT activity (IC50: 0.514 nM). NVP-2 shows inhibitory effcts on CDK1/CycB, CD... | |||
T6080 | NVP-AEW541 | AEW541 | FLT , Tyrosine Kinases , IGF-1R , Autophagy |
NVP-AEW541 (AEW541), a potent inhibitor of IGF-1R(IC50=150 nM) and InsR(IC50=140 nM), exhibits excellent efficiency and specificity for IGF-1R in a cell-based assay. | |||
TQ0231 | NVP-CGM097 | CGM097 | Mdm2 , E1/E2/E3 Enzyme |
NVP-CGM097 (CGM097) is an effective and specific MDM2 inhibitor (IC50: 1.7 nM for hMDM2). | |||
T3261 | NVP-TNKS656 | TNKS656 | Apoptosis , PARP , Wnt/beta-catenin |
NVP-TNKS656 (TNKS656) is a highly potent, selective, and orally active TNKS2 inhibitor. | |||
TQ0068 | NVP-LCQ195 | AT9311,LCQ-195 | CDK |
NVP-LCQ195 (LCQ-195) (AT9311) is a potent inhibitor of CDK1, CDK2, CDK3 and CDK5 (IC50: 1-42 nM). | |||
T3463 | NVP-ACC789 | ACC-789,ZK202650 | VEGFR , PDGFR |
ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases. | |||
T6079 | NVP-ADW742 | ADW742,ADW,GSK 552602A | Apoptosis , IGF-1R |
NVP-ADW742 (ADW) is an IGF-1R inhibitor with IC50 of 0.17 μM, >16-fold more potent against IGF-1R than InsR; little activity to HER2, PDGFR, VEGFR-2, Bcr-Abl and c-Kit. | |||
T19487 | NVP-BHG712 isomer | Ephrin Receptor | |
NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4. | |||
T3641 | NVP-BAW2881 | BAW2881 | Raf , VEGFR , Bcr-Abl |
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation. | |||
T6118 | NVP-HSP990 | HSP990 | Apoptosis , HSP |
NVP-HSP990 (HSP990) is an effective and specific HSP90α/β inhibitor (IC50: 0.6 /0.8 nM). | |||
T1918 | NVP-TAE 226 | TAE226 | Apoptosis , FAK , c-Met/HGFR , PYK2 , IGF-1R |
NVP-TAE 226 (TAE226) is an effective FAK inhibitor (IC50: 5.5 nM) and most effective to Pyk2(IC50: 3.5 nM); 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK. | |||
T2114 | VER-82576 | NVP-BEP800 | HSP |
VER-82576 (NVP-BEP800), a synthetic HSP90β inhibitor (IC50: 58 nM), exhibits >70-fold selectivity against Hsp90 family members Trap-1 and Grp94. | |||
T2251 | NVP-TAE 684 | TAE684 | Apoptosis , ALK |
NVP-TAE 684 (TAE684) is a excellently effective and specific ALK inhibitor(IC50=3 nM). | |||
T5555 | Siremadlin | NVP-HDM 201 | E1/E2/E3 Enzyme |
Siremadlin (NVP-HDM 201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor. | |||
T39858 | NVP-BSK805 trihydrochloride | NVP-BSK805 trihydrochloride | |
NVP-BSK805 trihydrochloride is a potent ATP-competitive inhibitor of JAK2, exhibiting IC50 values of 0.48 nM, 31.63 nM, 18.68 nM, and 10.76 nM against JAK2 JH1, JAK1 JH1, JAK3 JH1, and TYK2 JH1, respectively. |